WAT·Waters Corporation

Waters Corporation, a global provider of analytical workflow solutions, operates in the Healthcare sector's Diagnostics & Research industry. The company designs, manufactures, and services high-performance liquid chromatography and mass spectrometry systems, along with consumables and services, crucial for applications like drug discovery and environmental testing. In its most recent reported quarters, Waters demonstrated a mixed performance against analyst expectations. For Q1 2026, the company reported an Earnings Per Share (EPS) of $2.70 against an estimate of $2.36, and revenue of $1.27 billion against an estimate of $1.22 billion, indicating a beat on both fronts. This follows a strong Q4 2025 where EPS was $4.53, significantly exceeding the estimate of $2.47, and revenue reached $932.36 million, surpassing the estimate of $711.61 million. Looking at the historical trajectory, Waters has shown a pattern of exceeding EPS estimates in recent quarters, notably in Q4 2025 and Q1 2026, and has also met or exceeded revenue expectations when reported. The company has a history of delivering strong results, often beating analyst predictions for both earnings and revenue, suggesting a consistent operational capability. Recent news indicates that Wells Fargo raised its price target for Waters to $370, maintaining an Equalweight rating, following the finalization of its merger with BD’s Biosciences and Diagnostic Solutions businesses. This transformative transaction is expected to more than double the company's revenue base, with a focus on operational synergies and growth in key markets. However, a Massachusetts District Court denied Waters' motion to dismiss patent infringement claims related to mass spectrometry ionization technology, allowing the case to proceed. Investors will be closely watching the integration progress of the BD merger and the impact of the ongoing patent litigation on the company's future performance, particularly how the combined entity capitalizes on its expanded revenue base and navigates legal challenges.